Reconstituted MT-1 must be refrigerated at 28C immediately after mixing and kept there continuously except during transport for injection
Take 1-2 capsules 1 to 3 times daily as needed
In one embodiment, controlled release formulations or compositions are made through the incorporation of the otic agents and/or other pharmaceutical agents into ethylene-vinyl acetate copolymer matrices
The medication may be delivered into the lower abdomen, thighs, or arms, with the injection site rotating each week to avoid overuse
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide influence appetite, satiety, and gastric emptying
10.1038/nrgastro.2016.53 33 ShahB